Estimating the rate and reasons of clinical trial failure in urologic oncology
- 1 March 2021
- journal article
- review article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 39 (3) , 154-160
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
This publication has 19 references indexed in Scilit:
- Maturation of effect size during enrollment of prospective randomized trialsJournal of Surgical Research, 2018
- Strategies to improve recruitment to randomised trialsCochrane Database of Systematic Reviews, 2018
- A Randomized Controlled Trial of an Additional Funding Intervention to Improve Clinical Trial EnrollmentJournal of the National Comprehensive Cancer Network, 2017
- Telemedicine Provides Noninferior Research Informed Consent for Remote Study Enrollment: A Randomized Controlled TrialAcademic Emergency Medicine, 2016
- Optimising recruitment and informed consent in randomised controlled trials: the development and implementation of the Quintet Recruitment Intervention (QRI)Trials, 2016
- A Comprehensive Program for the Enhancement of Accrual to Clinical TrialsAnnals of Surgical Oncology, 2016
- Adult Cancer Clinical Trials That Fail to Complete: An Epidemic?JNCI: Journal of the National Cancer Institute, 2014
- Enrollment of research subjects through telemedicine networks in a multicenter acute intracerebral hemorrhage clinical trial: design and methods.2014
- Achieving Sufficient Accrual to Address the Primary Endpoint in Phase III Clinical Trials from U.S. Cooperative Oncology GroupsClinical Cancer Research, 2012
- Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi‐arm, multistage randomized controlled trialBJU International, 2009